C. Roux, A. Saraux, L. Bihan, E. Fardellone, P. Guggenbuhl et al., Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France, J Rheumatol, vol.34, pp.117-139, 2007.

L. Loet, X. Berthelot, J. Cantagrel, A. Combe, B. et al., Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology, Annals of the Rheumatic Diseases, vol.65, issue.1, pp.45-50, 2006.
DOI : 10.1136/ard.2005.035436
URL : https://hal.archives-ouvertes.fr/hal-00503869

W. Kievit, J. Fransen, A. Oerlemans, H. Kuper, M. Van-de-laar et al., The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice, Annals of the Rheumatic Diseases, vol.66, issue.11, pp.1473-1481, 2007.
DOI : 10.1136/ard.2007.072447

J. Morel and B. Combe, How to predict prognosis in early rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, vol.19, issue.1, pp.137-183, 2005.
DOI : 10.1016/j.berh.2004.08.008

V. Seibert, A. Wiesner, T. Buschmann, and J. Meuer, Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip?? technology in proteomics research, Pathology - Research and Practice, vol.200, issue.2, pp.83-94, 2004.
DOI : 10.1016/j.prp.2004.01.010

S. Vorderwulbecke, S. Cleverley, S. Weinberger, and A. Wiesner, Protein quantification by the SELDI-TOF-MS???based ProteinChip?? System, Nature Methods, vol.14, issue.5, pp.393-398, 2005.
DOI : 10.1146/annurev.biophys.32.110601.141854

A. Hodgetts, M. Levin, J. Kroll, and P. Langford, Biomarker discovery in infectious diseases using SELDI, Future Microbiology, vol.2, issue.1, pp.35-49, 2007.
DOI : 10.2217/17460913.2.1.35

P. Davidsson and M. Sjögren, Proteome studies of CSF in AD patients, Mechanisms of Ageing and Development, vol.127, issue.2, pp.133-140, 2006.
DOI : 10.1016/j.mad.2005.09.021

Z. Zhang, R. Bast, Y. Yu, J. Li, L. Sokoll et al., Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer, Cancer Research, vol.64, issue.16, pp.5882-90, 2004.
DOI : 10.1158/0008-5472.CAN-04-0746

C. Clarke, J. Buckley, and E. Fung, SELDI-TOF-MS proteomics of breast cancer, Clinical Chemical Laboratory Medicine, vol.43, issue.12, pp.1314-1334, 2005.
DOI : 10.1515/CCLM.2005.225

J. Mueller, F. Von-eggeling, D. Driesch, J. Schubert, C. Melle et al., ProteinChip Technology Reveals Distinctive Protein Expression Profiles in the Urine of Bladder Cancer Patients, European Urology, vol.47, issue.6, pp.885-93, 2005.
DOI : 10.1016/j.eururo.2005.02.016

V. Seibert, M. Ebert, and T. Buschmann, Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery, Briefings in Functional Genomics and Proteomics, vol.4, issue.1, pp.16-26, 2005.
DOI : 10.1093/bfgp/4.1.16

T. Uchida, A. Fukawa, M. Uchida, K. Fujita, and K. Saito, Application of a Novel Protein Biochip Technology for Detection and Identification of Rheumatoid Arthritis Biomarkers in Synovial Fluid, Journal of Proteome Research, vol.1, issue.6
DOI : 10.1021/pr025531w

D. Seny, D. Fillet, M. Meuwis, M. Geurts, P. Lutteri et al., Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach, Arthritis & Rheumatism, vol.5, issue.12, pp.3801-3813, 2005.
DOI : 10.1002/art.21607

H. Marotte, B. Pallot-prades, L. Grange, J. Tebib, P. Gaudin et al., The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population, Annals of the Rheumatic Diseases, vol.65, issue.3, pp.342-349, 2006.
DOI : 10.1136/ard.2005.037150
URL : https://hal.archives-ouvertes.fr/hal-00399217

M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Analytical Biochemistry, vol.72, issue.1-2, pp.248-54, 1976.
DOI : 10.1016/0003-2697(76)90527-3

L. Breiman, J. Freidman, R. Olshen, and C. Stone, Classification and regression trees, 1984.

R. Vermeulen, Q. Lan, L. Zhang, L. Gunn, D. Mccarthy et al., Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics, Proceedings of the National Academy of Sciences, vol.102, issue.47, pp.17041-17047, 2005.
DOI : 10.1073/pnas.0508573102

Y. Lam, J. Mobley, J. Evans, J. Carmody, and S. Ho, Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer, PROTEOMICS, vol.87, issue.11, pp.2927-2965, 2005.
DOI : 10.1002/pmic.200401165

J. Lakatos and A. Harsagyi, Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis, Clinical Biochemistry, vol.21, issue.2, pp.93-99, 1988.
DOI : 10.1016/S0009-9120(88)80094-8

N. Doherty, B. Littman, K. Reilly, A. Swindell, J. Buss et al., Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis, Electrophoresis, vol.15, issue.2, pp.355-63, 1998.
DOI : 10.1002/elps.1150190234

Y. Park, S. Lee, W. Lee, C. Suh, C. Lee et al., Lipid profiles in untreated patients with rheumatoid arthritis, J Rheumatol, vol.26, pp.1701-1705, 1999.

Y. Park, H. Choi, M. Kim, W. Lee, J. Song et al., Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study, The American Journal of Medicine, vol.113, issue.3, pp.188-93, 2002.
DOI : 10.1016/S0002-9343(02)01186-5

J. Dayer, The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis, Joint Bone Spine, vol.69, issue.2, pp.123-155, 2002.
DOI : 10.1016/S1297-319X(02)00363-9

B. Bresnihan, M. Gogarty, O. Fitzgerald, J. Dayer, and D. Burger, Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production ?, Arthritis Research & Therapy, vol.6, issue.6, pp.563-569, 2004.
DOI : 10.1186/ar1443

L. Ananth, P. Prete, and M. Kashyap, Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis, Metabolism, vol.42, issue.7, pp.803-809, 1993.
DOI : 10.1016/0026-0495(93)90050-X

D. Burger and J. Dayer, High-density lipoprotein-associated apolipoprotein A-I: the missing link between infection and chronic inflammation?, Autoimmunity Reviews, vol.1, issue.1-2, pp.111-118, 2002.
DOI : 10.1016/S1568-9972(01)00018-0

C. Chenaud, P. Merlani, P. Roux-lombard, D. Burger, S. Harbarth et al., Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation*, Critical Care Medicine, vol.32, issue.3, pp.632-639, 2004.
DOI : 10.1097/01.CCM.0000114820.47460.0A

A. Voskuyl, Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis, Ann Rheum Dis, vol.66, pp.184-192, 2007.

A. Slunggard, Platelet factor 4: a chemokine enigma, The International Journal of Biochemistry & Cell Biology, vol.37, issue.6, pp.1162-1169, 2005.
DOI : 10.1016/j.biocel.2004.12.003

G. Endresen, Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis, Rheumatology International, vol.24, issue.1, pp.19-24, 1989.
DOI : 10.1007/BF00270285

T. Yamamoto, T. Chikungo, and Y. Tanaka, Elevated plasma levels of ? ?thromboglobulin and platelet factor 4 in patients with rheumatoid disorders and cutaneous vasculitis

M. Meuwis, M. Fillet, L. Lutteri, R. Marée, P. Geurts et al., Proteomics for prediction and characterization of response to infliximab in Crohn disease, Clin. Biochem

B. Kasper, E. Brandt, S. Bulfone-paus, and F. Petersen, Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase, Blood, vol.103, issue.5, pp.1602-1612, 2004.
DOI : 10.1182/blood-2003-08-2802

B. Scheuerer, M. Ernst, I. Dürrbaum-landmann, J. Fleischer, E. Grage-griebenow et al., The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages, Blood, vol.95, pp.1158-66, 2000.